Role of Cardiopulmonary Exercise Testing in People With Heart Failure With Preserved Ejection Fraction
The Role of Cardiopulmonary Exercise Testing in People With Heart Failure With Preserved Ejection Fraction
3 other identifiers
observational
40
1 country
1
Brief Summary
Heart failure affects 1-2% of the adult population. Up to half of these patients have apparently normal heart pumping function, known as heart failure with preserved ejection fraction (HFpEF). Because HFpEF typically occurs in elderly patients with multiple comorbidities, many different mechanisms could drive symptoms and life expectancy, and it has been difficult to find effective treatments that work for all. Symptoms of HFpEF occur during exertion. The current scoring system for the diagnosis of HFpEF is not able to identify the majority of people and the majority of people remain in the zone of diagnostic uncertainty; there is no definite follow-up strategy, thus people do not receive appropriate treatment. Also, the medications, prehabilitation, and rehabilitation services are not personalised. To cater to these gaps in clinical practice, this study was set up to use Cardiopulmonary exercise testing (CPET) to understand the complexity of this disease. The investigators plan to recruit patients with clinical suspicion of HFpEF, referred to the Cardiology Department at Ulster Hospital, Belfast, UK. After screening the medical records of patients based on the inclusion and exclusion criteria, the investigators recruited 40 patients to undergo a cardiopulmonary exercise test. CPET parameters related to the heart, lungs and muscles were recorded in real time, as the patient exercised on the bike to maximal effort. The CPET data were then analysed to answer the above-mentioned clinical gaps. To disseminate the findings, the investigators plan to present the results at scientific, clinical, and patient group meetings and publish the findings in medical journals, to reach a wide array of healthcare professionals and policymakers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedFebruary 6, 2026
January 1, 2026
2 years
January 21, 2026
January 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum Oxygen Consumption at peak exercise (VO2peak)
Measure of exercise capacity.
CPET testing day. VO2peak is recorded as the oxygen consumption value measured by the gas sensor at the peak of exercise, i.e., seconds before maximal exhaustion.
Secondary Outcomes (3)
First Ventilatory Threshold
CPET testing day. Measured during the initial 3 minutes of the incremental test phase.
Heart Rate
Baseline, every 2 minutes interval, and at peak exercise near maximal exhaustion.
Blood Pressure
Every 3-minute interval during the exercise test.
Study Arms (1)
Patents referred to Cardiology Department with a clinical suspicion of HFpEF
Males and Females Age range: 18 to 80 Ejection fraction \>50% on the latest Echocardiography No Hospital admission in the past 6 months No pregnant No absolute contraindication for conducting an exercise test.
Interventions
It is the gold standard for assessing cardiorespiratory fitness. It assesses the combined functional capacity of the multiple systems of the body.
Eligibility Criteria
Patients registered with the South Eastern Health and Social Trust (NHS), Northern Ireland, UK.
You may qualify if:
- Male and female
- Age range between 18 - 80 years
- Clinical suspicion of Heart failure with preserved ejection fraction
- Ejection Fraction of ≥50% on the most recent Echocardiogram
- Able to understand the performance of an exercise test and the ability to provide consent
- Ability to undertake leg exercise without any impediment
You may not qualify if:
- Hospital admission in the past 6 months
- Unable to understand the performance of an exercise test
- Unable to provide informed consent
- Female subjects who are knowingly pregnant or believe they may be pregnant
- Having an impediment preventing them from performing cycle ergometry
- Contra-indication of CPET: acute myocardial infarction, unstable angina, uncontrolled arrhythmias, moderate or severe valvular disease, High-degree atrioventricular block, acute infection, acute endocarditis, myocarditis, uncontrolled asthma, and history of syncope.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ulsterlead
- Ulster Hospital, Northern Irelandcollaborator
Study Sites (1)
Ulster University and Ulster Hospital
Belfast, Middlesex, BT16 1RH, United Kingdom
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chris Bleakley, PhD
Ulster University, Belfast, UK
- STUDY DIRECTOR
George Kernohan, PhD
Ulster University, Belfast, UK
- STUDY DIRECTOR
Peter McKavanagh, MD, PhD
Ulster Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2026
First Posted
February 6, 2026
Study Start
June 1, 2023
Primary Completion
June 10, 2025
Study Completion
June 10, 2025
Last Updated
February 6, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- From March 2026 onwards
- Access Criteria
- Freely available online for anyone to access
Study Protocol